Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.
Merck & Co.
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Welireg: New Treatment for Tumors in Von Hippel–Lindau Disease
Belzutifan by Merck & Co. is for the treatment of renal cell carcinoma, central nervous system hemangioblastomas, and pancreatic neuroendocrine tumors.
Posted inNeuroscience, New Drugs, Regulatory
Lyfnua: First Drug for Refractory or Unexplained Chronic Cough
Gefapixant will reduce cough frequency, thereby improving patients’ quality of life.
Posted inNeuroscience, New Drugs, Regulatory
Quviviq: New Sleeping Pill
Daridorexant will help treat insomnia.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Molnupiravir Approved in the U.S.
An oral antiviral drug by Merck & Co. has joined the armamentarium of the pharmacological fight against COVID-19.
Posted inClinical Trials, COVID-19, Infections
Molnupiravir: New Effective Pill for Coronavirus. All That We Know
Molnupiravir pills by Merck & Co. can help COVID-19 patients avoid going to the hospital or dying.
Posted inInfections, New Drugs, Regulatory
Livtencity: New Drug Against Post-Transplant Cytomegalovirus Infection
Maribavir will suppress cytomegalovirus when ganciclovir, valganciclovir, cidofovir, or foscarnet do not work.
